A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT01364662 · COMPLETED
Trial details
- NCT number
- NCT01364662
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.